Jessica Sachs
Chief Tech/Sci/R&D Officer presso COGENT BIOSCIENCES, INC.
Patrimonio netto: 8 709 $ in data 31/03/2024
Profilo
Jessica Sachs is currently the Chief Medical Officer at Cogent Biosciences, Inc. She previously worked as an Associate Director at Genzyme Corp.
from 2010 to 2012 and as a Senior Medical Director-Clinical Research at Takeda Pharmaceutical Co., Ltd.
from 2012 to 2017.
Dr. Sachs holds a doctorate degree from Washington University in St. Louis and an undergraduate degree from Duke University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
COGENT BIOSCIENCES, INC.
0.00% | 22/02/2024 | 1 296 ( 0.00% ) | 8 709 $ | 31/03/2024 |
Posizioni attive di Jessica Sachs
| Società | Posizione | Inizio |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/06/2019 |
Precedenti posizioni note di Jessica Sachs
| Società | Posizione | Fine |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/04/2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2012 |
Formazione di Jessica Sachs
| Washington University in St. Louis | Doctorate Degree |
| Duke University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Jessica Sachs
